NCT04294160CompletedPhase 1
A study of safety and efficacy of novel targeted therapy combinations in adult patients with advanced or metastatic colorectal cancer.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 10 Jun 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 35 (actual)
- First submitted
- 5 Jun 2024
- Start date
- 5 Aug 2020
- Lead sponsor
- Novartis Pharma AG
- Diseases
- Colorectal cancer
- NCT number
- NCT04294160
- EU CT number
- 2023-510379-77-00
- EudraCT number
- 2019-004688-27
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 35
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitari Vall d'Hebron Coordinator of this site? Confirm its status | Barcelona | Spain | Completed |
| Hospital General Universitario Gregorio Marañón Coordinator of this site? Confirm its status | Madrid | Spain | Completed |
| Hospital Clinico Universitario de Valencia Coordinator of this site? Confirm its status | Valencia | Spain | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.